Sonova (OTCMKTS:SONVY) Shares Gap Up - Should You Buy?

Key Points

• Sonova gapped up pre-market Tuesday, opening at $52.70 versus a prior close of $49.54 and last trading at $51.99 on volume of about 49,820 shares.
• The analyst consensus is a Hold (1 Strong Buy, 1 Buy, 4 Hold, 2 Sell), with recent upgrades from Zacks (strong sell → hold) and RBC (to moderate buy).
• Key fundamentals show a debt-to-equity of 0.51, current ratio 1.24 and quick ratio 0.91; the stock trades near its 50-day ($52.85) and 200-day ($53.82) moving averages, and Sonova is a Switzerland-based hearing-care provider (brands include Phonak, Unitron and Advanced Bionics).

Sonova Holding (OTCMKTS:SONVY - Get Free Report) gapped up prior to trading on Tuesday . The stock had previously closed at $49.54, but opened at $52.70. Sonova shares last traded at $51.99, with a volume of 49,820 shares changing hands.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on the company. Zacks Research upgraded Sonova from a "strong sell" rating to a "hold" rating in a research note on Monday, February 9th. Royal Bank Of Canada upgraded shares of Sonova to a "moderate buy" rating in a research report on Tuesday, November 18th. One investment analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, four have issued a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold".

Sonova Stock Performance

The company has a debt-to-equity ratio of 0.51, a current ratio of 1.24 and a quick ratio of 0.91. The firm has a fifty day moving average of $52.85 and a 200-day moving average of $53.82.

About Sonova

Sonova AG OTCMKTS: SONVY is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.